Literature DB >> 6189906

Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells.

M Kannagi, K Sugamura, H Sato, K Okochi, H Uchino, Y Hinuma.   

Abstract

Human cytotoxic T cells (Tc) specific for autologous adult T cell leukemia virus- (ATLV) bearing cells were induced in vitro. Peripheral blood leukocytes (PBL) from healthy donors were stimulated repeatedly with autologous ATLV-bearing T cells. In two out of four seropositive donors and one out of two seronegative donors, the responder cells showed cytotoxicity for autologous ATLV-bearing cells, but not for autologous PBL, autologous cloned T cell lines, Epstein Barr virus-transformed autologous lymphoblastoid B cell line (LCL) cells, or various ATLV-negative cell line cells. The effector cells induced were cytotoxic T cells possessing Leu-1 and Leu-2a antigens that were able to proliferate continuously in vitro with periodic restimulation by appropriate cells and supplementation with partially purified T cell growth factor (TCGF). Of three Tc lines tested, one exhibited significant cytotoxicity against allogeneic ATLV-bearing cells that shared HLA-A2 antigen with the effector cells, possibly indicating HLA-restriction of ATLV-specific Tc. HLA-restriction was also suggested by cold target inhibition of cytotoxicity. Interestingly, Tc from this individual could also kill fresh adult T cell leukemia cells that were not expressing the ATLV surface antigens. These results, together with the target specificities of other Tc lines, suggest the possibility of at least two distinct target antigens recognized by ATLV-specific Tc, with one of these antigens differing from the ones detected by serologic methods.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6189906

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Improvement of simultaneous detection of antibodies to Gag and envelope antigens of human T-lymphotropic virus type I by western immunoblot assay.

Authors:  H Miyakoshi; M Sugimoto; H Igarashi; H Honda; R Fujino; M Mizukoshi
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

2.  Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus.

Authors:  C R Bangham; A J McMichael
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 3.  Direct identification of tumor-associated peptide antigens.

Authors:  V H Engelhard
Journal:  Springer Semin Immunopathol       Date:  1996

Review 4.  The clinical immunobiology of interleukin-2: potential modified uses for improved cancer treatment.

Authors:  S D Voss; G Weil-Hillman; J A Hank; J A Sosman; P M Sondel
Journal:  Bull N Y Acad Med       Date:  1989-01

5.  Human T-cell leukemia virus type-I (HTLV-I) tax is not the only one factor to enhance human immunodeficiency virus type-I (HIV-1) infection in culture-supernatants.

Authors:  A Tempaku; Y Maeda; W Song; S Harada
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

Review 6.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

7.  p21X mRNA is expressed as a singly spliced pX transcript from defective provirus genomes having a partial deletion of the pol-env region in human T-cell leukemia virus type 1-infected cells.

Authors:  S Orita; H Kobayashi; Y Aono; A Saiga; M Maeda; H Igarashi
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

8.  Correlation of major histocompatibility complex class I downregulation with resistance of human T-cell leukemia virus type 1-infected T cells to cytotoxic T-lymphocyte killing in a rat model.

Authors:  Takashi Ohashi; Shino Hanabuchi; Reiko Suzuki; Hirotomo Kato; Takao Masuda; Mari Kannagi
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models.

Authors:  Tomonori Tsukahara; Ken Ohmine; Chihiro Yamamoto; Ryosuke Uchibori; Hiroyuki Ido; Takeshi Teruya; Masashi Urabe; Hiroaki Mizukami; Akihiro Kume; Masataka Nakamura; Junichi Mineno; Kazutoh Takesako; Isabelle Riviere; Michel Sadelain; Renier Brentjens; Keiya Ozawa
Journal:  Biochem Biophys Res Commun       Date:  2013-07-17       Impact factor: 3.575

10.  Expression of HTLV-specific polypeptides in various human T-cell lines.

Authors:  Y Koyanagi; Y Hinuma; J Schneider; T Chosa; G Hunsmann; N Kobayashi; M Hatanaka; N Yamamoto
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.